HealthcareServices

Global Viral Vector Affinity Resin Market Performance Report: Global Trends 2026–2030

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the viral vector affinity resin market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Viral Vector Affinity Resin Market in 2030?

The viral vector affinity resin market size has experienced rapid expansion in recent years. This market is anticipated to grow from $0.62 billion in 2025 to $0.72 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.2%. The historical growth of the market is primarily due to the expansion of viral vector research activities, the increasing utilization of chromatography in bioprocessing, the proliferation of gene therapy development programs, a rising demand for scalable purification solutions, and continuous improvements in resin manufacturing technologies.

The viral vector affinity resin market is projected to experience substantial growth over the coming years. This market is anticipated to reach a valuation of $1.3 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.9%. Key factors contributing to this expansion during the forecast period include the expanding commercialization of gene therapies, a heightened need for high-throughput purification platforms, the broadening of vaccine development pipelines, an increasing emphasis on cost-effective downstream processing, and the greater uptake of customized affinity resins. Noteworthy trends for the forecast period encompass the wider acceptance of high-capacity affinity resins, an increasing need for AAV and lentiviral purification solutions, the expanding utilization of single-use chromatography systems, the advancement of ligand-specific resin development, and an intensified focus on processing viral vectors to achieve high purity.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30426&type=smp

What Drivers Are Influencing Production Trends In The Viral Vector Affinity Resin Market?

The viral vector affinity resin market is anticipated to experience growth driven by the increasing integration of gene-based therapeutics. These advanced treatments modify or regulate gene expression within a patient’s cells through the use of DNA, RNA, or viral vectors. The expanding uptake of gene-based therapeutics is largely due to advancements in their delivery systems, which enable the safe, efficient, and targeted transport of genetic material into cells. Viral vector affinity resins bolster the adoption of gene-based therapeutics by providing high-purity, scalable purification solutions, making them optimal for viral vector manufacturing. They help alleviate downstream processing hurdles by efficiently isolating viral vectors from impurities, thereby enhancing production efficiency and facilitating broader clinical and commercial applications. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, marking an increase from five approvals in 2022. Therefore, the rising adoption of gene-based therapeutics is a primary factor fueling the expansion of the viral vector affinity resin market.

Which Segments Are Gaining Traction In The Viral Vector Affinity Resin Market?

The viral vector affinity resin market covered in this report is segmented –

1) By Product Type: Adenoviral Vector Affinity Resin, Lentiviral Vector Affinity Resin, Adeno-Associated Viral (AAV) Vector Affinity Resin, Retroviral Vector Affinity Resin, Other Product Types

2) By Application: Gene Therapy, Vaccine Development, Cell Therapy, Other Applications

3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Adenoviral Vector Affinity Resin: Cell Lysis-Based Adenoviral Vector Affinity Resin, Chromatography-Based Adenoviral Vector Affinity Resin, High-Capacity Adenoviral Vector Affinity Resin, Prepacked Column Adenoviral Vector Affinity Resin

2) By Lentiviral Vector Affinity Resin: High-Purity Lentiviral Vector Affinity Resin, Column-Based Lentiviral Vector Affinity Resin, Membrane Chromatography Lentiviral Vector Affinity Resin, Single-Use Lentiviral Vector Affinity Resin

3) By Adeno-Associated Viral Vector Affinity Resin: Serotype-Specific Adeno-Associated Viral Vector Affinity Resin, High-Capacity Adeno-Associated Viral Vector Affinity Resin, Prepacked Column Adeno-Associated Viral Vector Affinity Resin, Ligand-Based Adeno-Associated Viral Vector Affinity Resin

4) By Retroviral Vector Affinity Resin: High-Selectivity Retroviral Vector Affinity Resin, Column-Based Retroviral Vector Affinity Resin, Membrane-Based Retroviral Vector Affinity Resin, Prepacked Retroviral Vector Affinity Resin

5) By Other Product Types: Hybrid Viral Vector Affinity Resin, Multimodal Viral Vector Affinity Resin, Recombinant Ligand Affinity Resin, Customized Viral Vector Affinity Resin

Who Are The Core Companies Influencing Trends In The Viral Vector Affinity Resin Market?

Major companies operating in the viral vector affinity resin market are Thermo Fisher Scientific, GE Healthcare Technologies Inc., Repligen Corporation, Creative Biolabs, JNC Corporation, Aptamer Group, ChromaGenix Inc., Cytiva (Danaher Corporation), Merck KGaA, Sartorius AG, Purolite Life Sciences, Tosoh Bioscience, Bio-Rad Laboratories, Avantor Inc., Pall Corporation, Takara Bio Inc., Cube Biotech, Agilent Technologies, Promega Corporation, Kaneka Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/global-viral-vector-affinity-resin-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Viral Vector Affinity Resin Market?

North America was the largest region in the viral vector affinity resin market in 2025. The regions covered in the viral vector affinity resin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Viral Vector Affinity Resin Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30426&type=smp

Browse Through More Reports Similar to the Global Viral Vector Affinity Resin Market 2026, By The Business Research Company

Protein A Resin Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-a-resin-global-market-report

Oral Expectorant Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Viral And Non Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795